As of January 22, 2025, 23andMe (ME) has a market cap of $91.805 million USD. According to our data, 23andMe is ranked No.7750 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $91.80 M |
48.58%
|
Dec 31, 2024 | $61.79 M |
-82.22%
|
Dec 29, 2023 | $0.35 B |
-57.69%
|
Dec 30, 2022 | $0.82 B |
-67.57%
|
Dec 31, 2021 | $2.53 B |
-41.73%
|
Dec 31, 2020 | $4.35 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Illumina
ILMN
|
$22.26 B |
0.000 M
|
USA
|
Thermo Fisher Scientific
TMO
|
$219.73 B |
0.006 M
|
USA
|
23andMe
ME
|
$91.80 M |
24.978 M
|
USA
|
Myriad Genetics
MYGN
|
$1.12 B |
-0.000 M
|
USA
|
LabCorp
LH
|
$20.28 B |
0.001 M
|
USA
|
Quest Diagnostics
DGX
|
$16.91 B |
-0.000 M
|
USA
|
Exact Sciences
EXAS
|
$10.14 B |
0.000 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Fulgent Genetics
FLGT
|
$0.52 B |
0.000 M
|
USA
|
Veracyte
VCYT
|
$3.34 B |
-0.000 M
|
USA
|
Market Cap | = | ME Stock Price | * | ME Shares Outstanding |
= | $3.52 | * | 19.01 M | |
= | $91.80 M |